Best Biotech Investment Newsletters in 2026
NewsletterFIT tracks 3 newsletters that cover Biotech investment as a primary topic, 2 of them with posts in the last 90 days. By publicly shown subscriber count, the largest are The Century of Biology (28K).
Updated Nov 12, 2026 · sorted by publicly shown subscribers · methodology
- 1The Century of Biology28K subscribers
Substacklast post Jun 21, 2026
Data, companies, and ideas from the frontier of biology.
Likely audience: Biotech investors
- 2
beehiivEvery two weeks · last post 21 days ago
From recent posts: Encode Ideas publishes in-depth analysis of biotech sectors, clinical trial data, and specific company profiles for investors and industry professionals.
Likely audience: biotech investors
- 3
SubstackMonthly or less · last post 27 days ago
Clinical & Regulatory Catalysts Driving BioPharma & MedTech Stocks Started by SanaCurrents ("SC"), a service established to identify which stocks, valued entirely on the promise of developing a new, novel drug, has the…
Likely audience: biotech investors
Latest posts from these newsletters
- Buried In…Home | Encode Ideas
- Did Investors…Biotech Currents
- Biotech Needs…Home | Encode Ideas
- Coya: The…Home | Encode Ideas
- Xenon: A…Home | Encode Ideas
- Protara: Roster…Home | Encode Ideas
- ProMIS Delivered...Now…Home | Encode Ideas
- Talphera: Approaching…Home | Encode Ideas